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Ethics committees traditionally provide a triad of services that include ethics consultation, policy 
development and review, and ethics 
education. These services have evolved, 
in large part, to address the many ques-
tions and dilemmas brought by new 
medical technologies such as mechanical 
ventilation, cardiopulmonary resuscita-
tion, organ dialysis and transplantation, 
and artificial reproductive technologies, 
to name a few. Much of the training for 
ethics committee members has focused 
on ethics case consultation. This is not 
surprising, as ethics committee review of 
individual cases has been recommended 
by judicial opinions, and mandated by 
state laws (including Maryland’s Health 
Care Decisions Act and Patient Care 
Advisory Committee Act) and the Joint 
Commission’s accreditation standards. 
While many would agree that ethics con-
sultation provided by qualified individu-
als is a valuable service that should be 
available in health care facilities, some 
have questioned whether there has been 
too much focus on ethics case consulta-
tion at the expense of other health care 
ethics services. 
The conference, "Ethics Consultation 
and Beyond: A Primer for Ethics Com-
mittee Members," held at Harbor Hos-
pital on June 29, 2011 and co-sponsored 
by MHECN, Harbor Hospital, and the 
Center for Ethics at Washington Hospital 
Center, focused on this broader range of 
services, in addition to case consultation. 
These services included proactive (also 
called “preventive”) ethics initiatives and 
BEYOND ETHICS CONSULTATION
quality improvement (QI) activities. 
Much of the ethics education provided 
by ethics committees falls in this cat-
egory of proactive ethics. The goal is 
to improve the knowledge and skills of 
health care staff so they can identify ethi-
cal issues, resolve basic ethical questions 
and conflicts, and know when and how to 
ask for help. Brian Childs, PhD, Direc-
tor of Ethics at Shore Health System in 
Easton, Maryland and participant in the 
“Proactive Ethics Applied” panel at the 
June 29 conference, described how he 
provides formal ethics education to new 
clinical staff at Shore Health. Fellow pan-
elist Robert Shabanowitz, PhD, Director 
of the ART/Andrology Laboratory and 
Chairman of the Bioethics Review and 
Advisory Committee at Geisinger Medi-
cal Center, shared educational resources 
that Geisinger’s ethics committee pro-
vides online (http://www.geisinger.org/
professionals/services/bioethics/). Dr. 
Shabanowitz raised a key concept—like 
ethics consultation, proactive ethics 
services should also be evaluated to 
determine if those services are achiev-
ing their identified goal. For example, 
he evaluated the number of hits different 
components of their bioethics web page 
received to know whether their educa-
tional offerings were being accessed.
A more formal approach to proactive 
ethics is found in QI activities. QI refers 
to the process of evaluating service qual-
ity, identifying quality gaps and goals to 
address the gaps, implementing systems 
or processes to achieve identified goals, 
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of ethics quality in health care: par-
ticular decisions and actions that are 
facilitated by ethics consultation (Fox, 
Berkowitz & Chanko, 2006), systems 
and processes that are facilitated by 
preventive ethics activities (Fox, Bot-
trell, Foglia & Stoeckle, 2006), and 
ethics environment and culture that is 
facilitated by ethics leadership (Fox, 
Crigger, Bottrell & Bauck, 2006). 
Preventive ethics involves the same 
steps applied in QI: identifying ethics 
quality gaps and the upstream systems 
and processes that contributed to or 
sustained the gaps, and intervening to 
minimize these gaps. 
For example, consider that your eth-
ics consultation service has handled 
repeated consultation requests from a 
renal dialysis center affiliated with your 
facility. A prior initiative to increase 
advance directive completion rates was 
successful, so the majority of patients 
have an advance directive on record. 
However, the documents are not rou-
tinely updated, and so there have been 
instances where patients communicated 
The Maryland Healthcare Ethics Committee Network (MHECN) is 
a membership organization, established by the Law and Health Care 
Program at the University of Maryland Francis King Carey School of Law. 
The purpose of MHECN is to facilitate and enhance ethical reflection in 
all aspects of decision making in health care settings by supporting and 
providing informational and educational resources to ethics committees 
serving health care institutions in the state of Maryland. The Network works 
to achieve this goal by:
   • Serving as a resource to ethics committees as they investigate  
 ethical dilemmas within their institution and as they strive to assist  
 their institution to act consistently with its mission statement;
   • Fostering communication and information sharing among Network  
      members;
   • Providing educational programs for ethics committee members, other 
      healthcare providers, and members of the general public on ethical  
 issues in health care; and
   • Conducting research to improve the functioning of ethics committees 
 and ultimately the care of patients in Maryland.
and re-evaluating whether identified 
goals were met. Proactive activi-
ties come into play in the step where 
systems and processes are identified 
to address a quality gap, such as a 
systemic source of recurring ethics 
consultations. Carol Taylor, RN, PhD, 
senior research scholar at the Kennedy 
Institute of Ethics, and professor in 
the Department of Medicine and in the 
School of Nursing and Health Studies 
at Georgetown University, addressed 
this topic at the June 29 conference. 
She provided three examples of qual-
ity gaps identified through ethics case 
consultations and how to address them 
at the organizational level. These in-
cluded a “problem physician,” patients 
“not dying well,” and provision of 
non-beneficial treatment causing moral 
distress among staff. 
The QI approach is consistent with 
the IntegratedEthics resources devel-
oped by the Veterans Affairs National 
Center for Ethics in Health Care, 
which identify three components 
Ethics Consultation 
Cont. from page 1
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informally to dialysis center staff that 
they wanted limits placed on the use 
of technology to prolong their life, but 
because this was not reflected in their 
written advance directive or witnessed 
as an oral directive, staff are uncertain 
how to proceed when the patient loses 
decision-making capacity. The quality 
ethics gap in this case could be framed 
as follows: “As confirmed by chart 
audit, 42% of the advance directives of 
dialysis patients are not updated annu-
ally or after a significant change in the 
patient’s health status, making it un-
clear if the document reflects current 
preferences.” A goal to address the 
gap could be: “Increase the percent of 
advance directives of dialysis patients 
that are updated annually or after a 
significant change in health status 
from 58% to 90% by [date]” (adapted 
from Foglia & Fox, 2010). The next 
steps would be to identify and imple-
ment process measures to achieve the 
goal, choose an appropriate outcome 
measure (e.g., % updated advance 
directives), and evaluate whether the 
goal was met. 
Evan DeRenzo, PhD, Senior Clini-
cal Bioethicist with the Center for 
Ethics at Washington Hospital Center 
(WHC), and Christina Emrich, RN, 
MS, Assistant Director for Quality at 
WHC, gave two examples of process 
measures that were implemented at 
WHC in response to an identified 
ethics quality gap involving staff not 
recognizing an ethical issue before it 
developed into a more intractable ethi-
cal conflict. Such conflicts impeded 
the ethical climate of the organization 
and the staff’s ability to provide excel-
lent patient care. The process mea-
sures that were implemented served to 
educate and empower staff members 
to identify and address ethical issues 
earlier in the course of a patient’s care 
trajectory. They were: (1) clinical 
ethicists joining “working rounds” in 
the intensive care unit (ICU) to help 
address ethical issues earlier in order 
to avoid future conflicts, dilemmas, or 
moral distress later; and (2) a clini-
cal ethicist joining “interdisciplinary 
rounds” in the ICU, which focus on 
patient care coordination through in-
depth discussion of complex patients, 
allowing ethical issues to be integrated 
into the patient’s plan of care. These 
interventions also demonstrate an 
effective approach to informal eth-
ics education within an institution—
similar to the type of ethics education 
that should occur during ethics case 
consultations. As pointed out above, 
effective ethics education is a proac-
tive ethics service that should be part 
of a health care institution’s broader 
ethics program.
Another example of a measure 
to provide incentive for health care 
personnel to take action to “do the 
right thing” (i.e., implement ethically 
appropriate actions) is the John J. 
Lynch, MD, Moral Courage Awards 
established by WHC. These are sepa-
rate awards to honor all categories of 
personnel at WHC who demonstrate 
moral courage, enhancing WHC’s 
culture by shining a light on the value 
that a “pro-ethics” environment brings 
to a health care institution. This un-
derscores the importance of effective 
ethics champions and leaders in the 
institution. 
MaryLou Lewis, MD, MA, Clini-
cal Ethicist at Charleston Area Medi-
cal Center (CAMC) in West Virginia, 
spoke at the June 29 conference on 
how to obtain buy-in from institutional 
leaders to support ethics programs in 
health care organizations. Actually, Dr. 
Lewis prefers the term “systems” over 
“organization,” as the former conveys 
how parts of an organization combine 
to form a complex and unitary whole, 
which is the focus of systems ethics. 
Indeed, CAMC has a “systems eth-
ics subcommittee” as part of its ethics 
program. Its mission is to address the 
ethical issues arising between internal 
hospital programs and departments 
within the clinical setting. Dr. Lewis 
gave practical suggestions for how 
to get institutional support for ethics 
services (see box on p. 4). 
What is needed at any health care 
institution are qualified individuals 
to advocate for and sustain an ethics 
program that provides effective ethics 
consultation, education, systems eth-
ics, and QI activities to ensure quality 
across the board. Leadership buy-in 
and at least one qualified “ethics 
champion” are essential. 
Anita J. Tarzian, PhD, RN
MHECN Program Coordinator
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HOW TO “SELL” AN ETHICS PROGRAM
Why is an Effective Ethics Program of Value?
• Improves the tone and atmosphere for the delivery of superior patient care. 
• Allows for the development of appropriate institutional policies.  
• Provides a forum for the discussion of ethical issues that affect services as they arise within and outside of 
the institution.
• Raises ethical consciousness at all levels of the institution, which fosters a patient-centered and caring en-
vironment.  
• Addresses moral distress among staff, which affects job satisfaction, productivity, and quality of care pro-
vided.
• Allows for the development of appropriate services and policies which protect the rights and responsibilities 
of both patient and health care providers.
• Adds to the “bottom line.” 
• Raises safety issues, which are ethical issues. 
• Identifies issues for risk management.
• Addresses new ethical issues arising due to new medical technology and scarce medical resources.
• Provides a good community liaison if community members participate.  
Ways to Gain Institutional Support
• Communicate your values, mission and goals through a mission statement, purpose and responsibilities. 
Educate, educate, educate.
• Request an opportunity to attend other meetings within your institution, e.g., performance improvement, 
quality, mortality, departmental. Contribute practical solutions. Volunteer. 
• Document activities, achievements, educational events, and services provided. Make it a part of the annual 
report to the quality committee of the Board of Trustees.  
• Develop a job description and reporting mechanism for the ethicist or support person.
• Develop a business plan with a budget and justification.
• Share your vision with the chief executive officer, chief operating officer, quality and compliance officers. 
Discuss “their” problems and offer assistance. Show how ethics services can decrease hospital length-of-
stay while improving quality of care, and resolve conflict.
Core Essentials of an Ethics Champion
• Be a Visionary: a person of unusually keen foresight. Present a vision of an ethics program, not just an 
ethics committee. 
• Be a Communicator. Learn to express your ideas clearly and to listen equally. 
• Be Tenacious and Patient (i.e., Persevere). Maintain the ethics program concept. 
• Be a low key Salesperson. Be willing to talk to anyone, anytime, about the program.
MaryLou Lewis, MD, MA
Clinical Ethicist, Charleston Area Medical Center
Charleston, West Virginia
From: How to “Sell” Ethics in Hard Times, Invited talk at “Ethics Consultation & Beyond: A Primer for Ethics 
Committee Members” held at Harbor Hospital, Baltimore, MD on June 29, 2011.
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TEN THINGS HEALTH CARE PROFESSIONALS SHOULD 
KNOW ABOUT MARYLAND MOLST
On May 19, 2011, Governor Martin O’Malley signed House Bill 82 into law, which recognizes the “Medical 
Orders for Life–Sustaining Treatment” (MOLST) form as a medical order form containing a patient’s preferenc-
es for treatment based on the patient’s current conditions and wishes. The Department's initial plan aimed for 
implementation of this form on October 1, 2011. However, the period for public comment was extended. Check 
the web link at the bottom of this page for updates. 
1. Maryland MOLST is a portable and enduring medical order form signed by a physician or nurse practitioner. 
It contains orders about cardiopulmonary resuscitation and other life-sustaining treatments. The Department‘s 
initial plan aimed for implementation of this form on October 1, 2011. However, the period for public com-
ment was extended. Check the web link at the bottom of this page for updates.
2. MOLST orders are based on an informed discussion with a patient or authorized decision maker, a patient’s ad-
vance directive, or the determination of medical ineffectiveness. If the patient or authorized decision maker has 
not limited [medical] care, except as otherwise provided by law, CPR will be attempted and other treatments 
will be given. A patient has the right to decline to discuss these topics. 
3. MOLST helps to ensure that a patient’s wishes to receive or decline care are honored throughout the health 
care system. In every section of the order form, there are options to accept all medically indicated treatments or 
to limit interventions.
4. A copy of a completed MOLST form shall be given to the patient or authorized decision maker within 48 hours 
of completion or sooner if the patient is discharged or transferred.
5. MOLST replaces the Maryland EMS DNR order form and the Life-Sustaining Treatment Options form that 
were previously used, primarily in nursing homes. The original, a copy, and a faxed MOLST form are all valid 
orders.
6. Beginning October 1, 2011, MOLST must be completed for all individuals admitted to nursing homes, assisted 
living programs, hospices, home health agencies, and dialysis centers and for certain individuals admitted to 
hospitals. The form must also be completed for anyone who wants limitations on CPR or life-sustaining treat-
ments in any setting.
7. Any individual who has the capacity to make decisions may request that their physician or nurse practitioner 
complete the MOLST form for them.
8. Even if the practitioner who signs the MOLST form is not on a facility’s medical staff, the MOLST form is 
valid. MOLST orders are valid for EMS providers and for all health care professionals, providers, facilities, 
and programs across Maryland.
9. MOLST does not change the Health Care Decisions Act or an individual’s advance directive. It does not 
change who has the legal authority to make decisions on behalf of an individual who lacks the capacity to 
make health care decisions.
10. Orders on the MOLST form do not expire, but may be revised. To make sure the orders accurately reflect the 
patient’s current wishes, it must be reviewed annually. It must also be reviewed whenever the patient is trans-
ferred between health care facilities or programs, is discharged, has a substantial change in health status, loses 
capacity to make health care decisions, or changes his or her wishes.
These, along with other educational resources, are provided by the Maryland Department of Health and Mental 
Hygiene at http://dhmh.maryland.gov/marylandmolst.
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CASE PRESENTATION
One of the regular features of this Newsletter is the presentation of a case considered by an ethics committee and an 
analysis of the ethical issues involved. Readers are both encouraged to comment on the case or analysis and to submit 
other cases that their ethics committee has dealt with. In all cases, identifying information about patients and others in the 
case should only be provided with the permission of the patient. Unless otherwise indicated, our policy is not to identify 
the submitter or institution. We may also change facts to protect confidentiality. Cases and comments should be sent to  
MHECN@law.umaryland.edu, or MHECN, Law & Health Care Program, University of Maryland Francis King Carey 
School of Law, 500 W. Baltimore St., Baltimore, MD 21201.
ETHICS EDUCATION AVAILABLE VIA PODCAST
The use of technology as an educational tool has been increasing in popularity since the 1990s.  Learners of all 
types find education via mixed media valuable and interesting. In 2010, Dr. David Perlman from the University of 
Pennsylvania School of Nursing developed the Bioethics 2.0™ podcast series. These podcasts were grant funded 
and are freely available to the public through http://www.bioethics2.net and iTunes University. The 14 podcasts 
cover a variety of the most common issues in medical ethics, including:  
• Introduction to ethical theory
• Reasons and values in bioethics
• Clinical pragmatism framework
• Health law and clinical ethics
• Privacy and confidentiality
• Informed consent
• Death and dying
• Pediatrics 
Each podcast begins with learning objectives and then gives a citation as to where the section of the podcast 
was taken. The two main texts drawn from in these podcasts are Fletcher’s Introduction to Clinical Ethics and 
Schroeter’s Practical Ethics for Nursing Students: A Short Reference Manual. 
The podcast series was originally designed as a supplement to classroom learning for Dr. Perlman’s undergraduate 
nursing students, but he quickly realized that by making the podcasts available free of charge to anyone, people 
who serve on ethics committees might find them equally useful. As Dr. Perlman commented at his talk, “Strategies 
for Training Ethics Committee Members” at the June 29 conference at Harbor Hospital (see article on p. 1), the 
literature shows that frequently there is inadequate funding to educate ethics committee members and that such 
education varies greatly in quality and quantity. The Bioethics 2.0™ Podcasts are designed to bridge this gap. Dr. 
Perlman hopes to develop an eBook on this topic, which will be available in the Bioethics 2.0 Amazon.com Store.
Dr. Perlman’s podcasts exemplify the increased flexibility in the mediums used for education available to learners 
today. 
Kathryn G. Murphy 
David Perlman, PhD
CASE STUDY FROM  
A MARYLAND HOSPITAL
An 89 year old man, D.S., is admitted to the Emergency Department for trauma from 
a self-inflicted gunshot wound to the 
head. About three months earlier, 
he was diagnosed with Progressive 
Supranuclear Palsy, a degenerative 
neurological condition often confused 
with Parkinson’s that affects balance, 
among other things, leading to falls. 
The patient was treated for a shoulder 
fracture from a fall and then insisted 
on going back to his home. He was 
used to taking his daily walks and 
being independent. According to his 
82 year old brother, who was also his 
designated health care agent, D.S. was 
always very independent and resisted 
help from others. He has no living 
children or spouse.  He has no living 
will. 
He is transferred from the ED to the 
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ICU and maintained on a ventilator 
with other life support measures in 
place. His prognosis for surviving is 
uncertain, but if he does survive, he 
would require intensive rehabilitation 
and would most likely have substantial 
cognitive and physical impairments. 
His brother requests that life support 
be removed and a Do-Not-Attempt-
Resuscitation (DNAR) order be 
written, arguing that his brother was 
fiercely independent and had lived his 
life and was now ready to die. The 
ICU staff call for an ethics consulta-
tion because some staff are concerned 
that if they remove life support, they 
will be complicit in the patient’s sui-
cide.
RESPONSE FROM A PHYSICIAN 
& ETHICS COMMITTEE CHAIR
This case is difficult to discuss 
because it involves a voluntary act 
that some people believe to be socially 
and/or ethically unacceptable, that is, 
suicide. Suicide is unimaginable for 
many of us, but there are times when 
even the most staunch critic of suicide 
has to pause, as when people jumped 
to their death from the windows of 
the World Trade Center in 2001. In 
addition, there is a widespread belief 
and established tradition that physi-
cians or health care providers should 
never contribute to an activity that is 
non-benevolent, such as interrogation, 
homicide or suicide. Suicide is a polar-
izing subject, somewhat like abortion, 
and it is hard to discuss such matters 
without personal involvement. 
Suicide also involves, to the ultimate 
degree, the “A-Word,” autonomy; 
and suicide may actually be the most 
extreme instance of autonomous ac-
tion. When an autonomous individual 
makes a very genuine attempt to take 
his own life he makes an extremely 
strong statement about his most deeply 
held wishes.
It goes without saying that any 
medical center would mount a full 
resuscitative effort when a patient like 
D.S. arrives at the ED. After all, this is 
the purpose of the ED unit, to provide 
immediate care for patients who are 
seriously sick or wounded. However, 
when the younger brother arrives, 
and he is verified to be the designated 
health care agent (and it is important 
to examine the document, which needs 
to have two signed witnesses), the 
“stage” is reset, and autonomy again 
takes a major role.
Under the Maryland Health Care 
Decisions Act, a health care agent 
appointed in writing by a patient has 
considerably more power as a deci-
sion-maker than a surrogate decision-
maker. A surrogate decision-maker 
cannot decide to withdraw life support 
unless the patient has been declared 
to be either end-stage, terminal or in 
a persistent vegetative state, but the 
health care agent has no such restric-
tions. Just as a competent patient can 
do, a health care agent can decide to 
forego intensive care if he or she feels 
that the patient would not desire such 
care. This authority of the healthcare 
agent is spelled out in Maryland HG 
§5-602; surrogate decision makers 
have significantly restricted powers re-
garding the authorization of withdraw-
al of life-sustaining care, as described 
in Maryland HG §5-606.
Often health care agents are named 
in a document that provides some 
general guidelines for decision-mak-
ing, but in this case there is no such 
document that we know of. Such ac-
companying documents are desirable 
and should reflect the general attitudes 
and preferences of the patient, without 
being too restrictive. The information 
contained in such documents is not 
only helpful to the agent, but it is also 
helpful to health care providers who 
may want some supportive informa-
tion to ensure that the agent is follow-
ing the patient’s wishes.
Because there is no written confir-
mation of R.S.’s views, we have to 
rely on the credibility of the agent, 
and the brother’s statements about the 
patient sound very plausible. Since 
the patient, if he survives this period 
of intensive care, would very likely 
have massive disabilities, and since 
the agent is making a decision to 
withdraw life-sustaining care that is 
clearly consistent with what the patient 
himself would want if he could speak, 
it seems ethically acceptable that the 
patient should be declared DNAR 
and the ventilator turned off. This is a 
very reasonable example of respect for 
individual autonomy.
What if the brother were not the 
health care agent, but rather the only 
sibling and only surrogate? Of course, 
the case would be entirely different 
because, under the Health Care Deci-
sions Act, the brother would not have 
legal authority to consent to withdraw-
ing life-sustaining treatment (unless 
the patient became end-stage or termi-
nal). However, a DNAR order might 
still be in the patient’s best interest, 
given the grim prognosis. It would 
also be legally appropriate because, 
by definition, the patient would be 
terminal if he were to arrest (Schwartz, 
1999).
As an aside, just to illustrate how 
the case of D.S. might proceed if the 
caregivers were to refuse to honor the 
instructions of the health care agent, a 
recent ethics consult at my institution 
concerned a patient admitted to the ED 
with altered mental status and sepsis as 
the result of extremely poor personal 
care and substance abuse.  He was also 
morbidly obese, had prior myocardial 
infarctions and had a long history of 
refusing medical care. The patient had 
no advance directive and no living 
family members. The patient was not 
considered to be in either an end-stage 
or terminal condition. A friend, who 
knew him well for 42 years, stated 
that the patient wanted to die and that 
he would not want the intensive care 
that he was receiving. The friend’s 
testimony was entirely convincing, but 
because the Health Care Decisions Act 
was seen as limiting his authority to 
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Case Presentation 
Cont. from page 7
withdraw life-sustaining treatment, the 
patient proceeded to get a tracheosto-
my and a percutaneous gastric feeding 
tube, with the friend’s consent, and 
the patient was eventually placed in a 
long-term care facility. I don’t think 
that any of the healthcare providers or 
ethics consultants involved in this case 
were comfortable with the outcome, 
but the absence of clear legal authority 
for the friend to decline these inter-
ventions seemed to preclude a more 
palliative approach.
Even though the case of D.S. may 
appear straightforward from a legal 
perspective, it is still ethically charged: 
the ICU staff is understandably upset 
about their possible complicity in a 
“suicide” of a patient under their care. 
Perhaps there are two components to 
this “concern:” 1) professional ethics 
and 2) personal difficulties with moral 
subjectivity.
The AMA Code of Medical Ethics 
regards physician-assisted suicide as 
“fundamentally incompatible with 
the physician’s role as healer” (AMA 
Code of Medical Ethics, Opinion 
2.211). Physicians might regard 
withdrawing life-sustaining care in a 
situation where the patient is neither 
end-stage nor terminal as assisting in a 
suicide, and this professional discom-
fort may trump their concerns for pa-
tient autonomy. Further, the Maryland 
Healthcare Decisions Act states in §5-
611 that “nothing in this subtitle may 
be construed to require a physician to 
prescribe or render medical treatment 
to a patient that the physician deter-
mines to be ethically inappropriate.” 
This would support not compelling 
health care providers to withholding 
life-sustaining treatment from D.S. if 
they consider this to be assisting with 
a suicide. Similarly, the American 
Nurses Association’s Code of Ethics 
states that “nurses may not act with 
the sole intent of ending a patient’s 
life even though such action may be 
motivated by compassion, respect for 
patient autonomy and quality of life 
considerations” (ANA Code of Ethics 
for Nurses, Provision 1.3).
Secondly, the healthcare providers 
may simply be experiencing personal 
difficulty with “moral subjectivity,” as 
discussed by Mark Repenshek (2010) 
in a recent MAEC newsletter. Even 
if D.S.’s physicians and nurses are 
comfortable with the brother’s author-
ity as the designated health agent, they 
don’t have to be comfortable with his 
decision.
No matter what the outcome of this 
case, there needs to be one or more 
meetings between ethics committee 
consultants and the concerned per-
sonnel in the ICU in order to work 
through the various bioethical and 
legal issues.
Paul S. Van Nice, MD, PhD, MA
Chairman, Ethics Committee
Shady Grove Adventist Hospital
Rockville, Maryland
The author acknowledges the sug-
gestions of Carol Chandler, RN, and 
Sigrid Haines, JD, regarding some 
aspects of the above article.
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RESPONSE FROM A STAFF  
   PHYSICIAN
The following commentary was written 
in response to a different, but similar, 
case: Bartlett, VL, Killu, C, Finder, S, 
& Hackner, D (2010). Clinical Ethics 
in the ICU: A Case of Attempted Sui-
cide. ICU Director, 1(6), 312-317. It is 
reprinted here with permission.
Suicide victims present an ethical 
dilemma to the medical community. 
The dilemma rises when a patient 
committing suicide is in the hands 
of physicians who face two contrast-
ing decisions of life and death and 
whether to treat or not. This dilemma 
is especially challenging when com-
plicated by autonomy and the “right 
to die.” The challenge becomes even 
larger when decisional capacity of the 
suicidal person is questioned or the pa-
tient temporarily lacks capacity. Even 
in the situation of attempted suicide, 
the cornerstones of assessment are 
founded on medical ethics and the four 
moral principles familiar to clinicians: 
respect for autonomy, nonmaleficence, 
beneficence, and (distributive) jus-
tice (Beauchamp & Childress, 2001). 
These principles are guideposts for cli-
nicians in their practice and conduct in 
such difficult cases. Autonomy deals 
with respect for individual self-deter-
mination and calls for respect, dignity, 
and choice for all suicidal patients. But 
beneficence calls for doing the great-
est good possible, and physicians must 
not discard this moral principle for a 
seemingly “autonomous” choice when 
a patient who has attempted suicide 
was acting irrationally and indeed 
without capacity. While nonmalefi-
cence calls for minimizing and pre-
venting harm, physicians must strive 
to protect their patients, especially in a 
situation where the physician’s act will 
cause harm, to avoid doing harm. The 
challenge here is what does the patient 
construe as benefit and harm? Finally, 
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distributive justice would ask us to 
establish principles that are broadly 
and fairly applicable.
Is it fair to treat one patient differ-
ently from another simply because 
of a bias regarding suicide? Suicide 
is considered an irrational act, and 
the assistance of a patient’s suicidal 
wishes prior to committing suicide is 
generally accepted as irrational and 
illegal. However, there is indeed sup-
port in some societies for physician-
assisted suicide, even giving rise to 
the “suicide tourist” (PBS Frontline, 
2010). In most cultures, actively as-
sisting suicide has been rejected, and 
the code of ethics, for example, from 
the American Medical Association 
states that “Physician assisted suicide 
is fundamentally incompatible with 
the physician’s role as healer, would 
be difficult or impossible to control, 
and would pose serious societal risks” 
(AMA, 1992).The argument is both 
from the standpoint of nonmaleficence 
as well as distributive justice. In most 
societies, suicide completes only 
when a patient dies without medical 
treatment, before reaching a hospital, 
or as a result of massive, untreatable 
injuries. The case of an uncompleted 
suicide poses a dilemma for clinicians.
When a patient seeks medical atten-
tion himself or is brought to a hospital 
by a health proxy, the implication is 
that this is a patient needing assis-
tance. Most cases of attempted suicide 
seen in the emergency department are 
suicide “gestures” with entirely differ-
ent motives than the carefully planning 
“suicide tourist.” Thirty percent to 
80% of suicide attempts are impulsive 
and related to self-limiting crises such 
as a break up of a romantic relation-
ship, loss of a job, or criminal justice 
encounter (Simon, Swann, & Powell, 
2001). Furthermore, 90% of persons 
who survive a suicide attempt, wheth-
er intended as a gesture or as a lethal 
act, survive to die by other natural and 
accidental causes (Id.) Most patients in 
such circumstances do not necessarily 
seek to end their lives but perhaps to 
change their lives; they are looking for 
help and not to be abandoned. Even 
among older adults aged 65 years and 
above, there are approximately four 
suicide attempts for every completed 
suicides (Suominen, et al., 2004; 
Gaynes, et al., 2004).  Attempted 
suicide patients most frequently need 
help, mentally and physically, and 
they do not access the care they need, 
sometimes seeking it in the form of a 
suicide attempt or perhaps abandon-
ing help they think is not available. 
Would we hesitate to pull an indi-
vidual away from an oncoming train 
in a last minute change of mind? Even 
if we make a distinction between two 
broad categories of suicide attempts, 
the long-term, volitional planning of 
a death and the sporadic attempted 
suicide, when a patient presents for 
medical care with an uncompleted sui-
cide, it is my opinion that there should 
be no dilemma or conflict. The most 
challenging scenario arises from the 
case of a patient who is brought to the 
hospital against [his] stated wishes and 
acts of planning to avoid medical care.
The principal act of a physician is 
to preserve life, but increasingly, we 
define life in both biological and func-
tional terms. Surely, complex life and 
death decisions, especially in cases 
of attempted suicide … should not 
be treated lightly. We should remind 
ourselves of the language of the Hip-
pocratic Oath (1964, Louis Lasagna): 
“Most especially must I tread with 
care in matters of life and death. If it 
is given me to save a life, all thanks. 
But it may also be within my power to 
take a life; this awesome responsibil-
ity must be faced with great humble-
ness and awareness of my own frailty. 
Above all, I must not play at God.” 
Such cases can produce moral distress 
for care givers. Hence, the team admit-
ting their bias to treat should carefully 
deliberate with the assistance of a 
neutral agency such as an ethics team.
Claude Killu MD
Staff Physician, Procedure Center 
and Intensive Care Unit
Division of General Internal 
Medicine, Cedars-Sinai
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SEPTEMBER
26 (12:15-1:30 PM) 
Noon Seminar Series on Values and Health: Global and Local Perspectives. Speaker: Robert Klitzman, MD, Associate 
Professor of Clinical Psychiatry at the Columbia University College of Physicians and Surgeons and the Mailman School 
of Public Health. Sponsored by the Berman Institute of Bioethics Seminar Series. Johns Hopkins University, 615 N Wolfe 
St, W3008. For more information/to register, visit http://www.bioethicsinstitute.org, or contact Michelle Martin-Daniels at 
michellemd@jhu.edu.
OCTOBER 
10 (12:15-1:30 PM) 
Noon Seminar Series on Values and Health: Global and Local Perspectives. Speakers: Ruth Macklin, PhD, Professor, De-
partment of Epidemiology & Population Health; Dr. Shoshanah Trachtenberg, Frackman Faculty Scholar in Biomedical 
Ethics, Albert Einstein College of Medicine of Yeshiva University. For more information, visit http://www.bioethicsinsti-
tute.org/ for title of talks. Sponsored by the Berman Institute of Bioethics Seminar Series, Johns Hopkins University. (See 
September 26 for location/contact details).
12 (5:30-7:30 PM) 
Ethics in the Age of the Internet. Presenter: Patti O’Donnell, PhD, LICSW, Director, Center for Ethics, Inova Health 
System. Inova Fairfax Hospital, Physician Conference Center, Lower Level, Rooms A and C, 3300 Gallows Road, Falls 
Church, VA. Contact Patti O’Donnell to register, at Patricia.o’donnell@inova.org or 703-289-7592.
13 (3 p.m. – 4:30 p.m. followed by a reception) 
Palliative Care: A Bridge of Compassion between Curing and Caring (as told through poetry, plays and prose), Presented 
by Vivienne Shub, resident member of Everyman Theater, Written by Naomi Greenberg, Dramaturg for Everyman 
Theater. University  of Maryland, Baltimore School of Pharmacy Auditorium, 20 North Pine St., Baltimore, MD. Spon-
sored by the UMB Geriatrics and Gerontology Education and Research Program. RSVP by October 10 to Reba Cornman, 
rcornman@umaryland.edu.
13-16 
American Society for Bioethics & Humanities 13th Annual Meeting, Hyatt Minneapolis, Minneapolis, MN. For more 
information, visit http://www.asbh.org .
19 (5:30-7:30 PM) 
Ethical Guidelines for Initiating and Discontinuing Dialysis. Presenter: David Mahoney, MD, Medical Staff, Inova Fair-
fax Hospital. (See October 12 location/contact details.)
27-28 
Conflicts of Interest in the Practice of Medicine: A National Symposium. American Society of Law, Medicine & Ethics. 
The University Club, University of Pittsburgh, Pittsburgh, PA. For more information, visit: http://www.aslme.org/Calen-
dar. 
NOVEMBER 
2 (5:30-7:30 PM) 
The Physicians Order Set for Life Sustaining Treatment (POLST): An Aid to Goals of Care Planning. Presenter: Kristen 
Smith, MSN, RN, MSW, Palliative Care Liaison, Dept of Care Management, Inova Health System. (See October 12 loca-
tion/contact details.)
3-5 
Ethics Consultation Boot Camp, Sponsored by the Provincial Health Ethics Network (PHEN), Banff, Alberta, Canada. 
For more information, visit http://www.phen.ab.ca/bootcamp/index.asp. 
CALENDAR OF EVENTS
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CALENDAR OF EVENTS (cont'd)
7 (8A-12N) 
Moral Agency and Moral Distress, Carol Taylor, PhD, RN, Georgetown University Center for Clinical Bioethics. 
Sponsored by the Center for Ethics and Professional Practice, Inova Health System. Inova Fairfax Hospital, Physicians 
Conference Center Auditorium, Fairfax, VA. Contact Patti O’Donnell to register, at Patricia.o’donnell@inova.org or 
703-289-7592.                                         
10-11 
Research Ethics: RE-Examining Key Concerns. Benson Center, Wake Forest University, Winston-Salem, NC. For more 
information, visit http://bioethics.wfu.edu/.
11 
Practice and Profession. Sponsored by the Program on Medicine and Religion at the University of Chicago. This sym-
posium will explore what it would mean to set the practice of medicine in the context of a good and faithful life. For 
more information, visit https://pmr.uchicago.edu/events .
11 (12:15-1:30 PM) 
Noon Seminar Series on Values and Health: Global and Local Perspectives. Speaker: Christine Grady, MSN, PHD- Act-
ing Chief, Department of Bioethics; Head, Section on Human Subjects Research. For more information, visit http://
www.bioethicsinstitute.org/ for title of talk. Sponsored by the Berman Institute of Bioethics Seminar Series, Johns 
Hopkins University. (See September 26 for location/contact details).
16 (5:30-7:30 PM)  
Futility in the NICU patient: Exploring Perspectives and Achieving Consensus. Presenter: Margot Ahronovich, MD, 
Neonatologist, Inova Fairfax Hospital for Children. (See October 12 location/contact details.)     
16 
Palliative Care Network Grand Rounds Audio Conference Series. Sponsored by the Center for Health Ethics and Law 
at West Virginia University’s Robert C. Byrd Health Sciences Center. For more information, contact Cindy Jamison 
(cjamison@hsc.wvu.edu; 1-877-209-8086), or visit http://www.wvethics.org/Calendar-of-Events. 
28 (12:15-1:30 PM) 
Noon Seminar Series on Values and Health: Global and Local Perspectives. Speaker: Duana Fullwiley, PhD, MA, As-
sociate Professor of Sociology, Columbia University. For more information, visit http://www.bioethicsinstitute.org/. 
Sponsored by the Berman Institute of Bioethics Seminar Series, Johns Hopkins University. (See September 26 for loca-
tion/contact details).
DECEMBER
5 (1 – 2 p.m.) 
Advance Directives and MOLST –  Medical Orders for Life Sustaining Treatment; New End-of-Life Care Legislation. 
Presented by Delegate Dan Morhaim, M.D., Maryland House of Delegates. University of Maryland, Baltimore, SMC 
Campus Center, Room 351, 621 W. Lombard St., Baltimore, MD. RSVP by December 5 to Reba Cornman, rcornman@
umaryland.edu . For additional MOLST training dates, visit http://dhmh.maryland.gov/marylandmolst/pages/training.
htm .
12 (12:15-1:30 PM)  
Noon Seminar Series Speaker: Joanne Lynn, MD, Director of the Center on Elder Care and Advanced Illness, Altarum 
Institute. For more information, visit http://www.bioethicsinstitute.org/. Sponsored by the Berman Institute of Bioethics 
Seminar Series, Johns Hopkins University. (See September 26 for location/contact details).
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